Prot #M16-573: A Phase 1 First-in-Human Study with ABBV-155 Alone and in Combination with Taxane Therapy in Adults with Relapsed and/or Refractory Solid Tumors

Project: Research project

StatusActive
Effective start/end date10/17/1910/17/20

Funding

  • AbbVie Inc. (Prot #M16-573)